Unilever PLC

Introducing the future of cleaning. If it's round, we can clean it. If it's yellow, we can clean it. Even if your dog thinks it's a toy, we can clean it. SIF Infinite Clean with probiotics technology. Clean surfaces throughout your home and beyond. So no matter its shape, size or colour, we can clean it. Try new SIF Infinite Clean probiotics technology.

Just like sun damages skin, UV damages hair four times more than heat styling, causing oxidative damage that dulls hair. Hair Care Breakthrough. New Dove UV Repair and Glow with Bioprotein Care and Ferulic Serum and Revolutionary Hair Protection Factor 70. It repairs 99% of internal UV hair damage and protects hair from dulling sun for 70 hours. Switch off internal UV hair damage. Switch on Ultimate Shine.

don't just taste the flavor feel the flavor with hellman's flavored mayo i've had this dream for as long as i can remember

bigger than any cup.

I want to create a legacy that people can look at and say, this guy changed American soccer.

Good morning and thank you for joining us for Unilever's first quarter trading statement for 2026. I'm joined today by Srini Patak, our Chief Financial Officer. In a moment Srini will take you through the detail of the quarter. I will also come back to say a few words on the recent announcement regarding our foods business and why we believe this is the right move for foods, for Unilever and ultimately for our shareholders that will unlock significant value. But first, let me set out what I see as the key elements of our performance in the first quarter. We made a good start to the year. Growth was solid, and importantly, in line with the strategic priorities we have set for the business. We delivered underlying sales growth of 3.8%, driven by a strong volume growth of 2.9% in the quarter. Growth was broad-based across categories, with a particularly strong quarter in home care, with volumes up 6.2%, driven by a strong innovation plan and good volumes in our two largest home care markets, India and Brazil. Our power brands, which represent around 78% of turnover, continue to lead the way, growing 5% in the quarter with volumes up 4%, reflecting the benefits of our high-quality innovation and focused investment behind these brands. Emerging markets perform well, with a further step up in volume growth to 4.2%. We saw strong performances in markets such as India, Turkey, and Vietnam. At the same time, those markets where we have taken decisive actions to improve competitiveness in Tunisia, China, Brazil, all continue to make good progress. Developed markets remain resilient in a challenging environment. North America delivered volumes of 2.2%, led by personal care and beauty, despite strong comparators. Europe remains more subdued, reflecting the softer backdrop. We also continue to make good progress against our strategic priorities, strengthening desire at scale across our portfolio and improving the quality of our execution. And I will come back to say more on this later. But first, over to Shini to take you through the results in more detail.

Thank you, Fernando. Let me start with our growth profile in the quarter. We delivered 3.8% underlying sales growth with volume at 2.9% and pricing at 0.9%, maintaining a strong volume-led growth profile. On a two-year basis, our volume growth remains robust at 2% CAGR, reflecting the improving quality and consistency of our growth. Looking at our performance on a quarterly basis, we have delivered average volume growth of 2.5% over the last nine quarters, demonstrating the resilience and repeatability of our model. This consistency reflects the progress we are making to elevate our brands and execute flawlessly in our markets through desire at scale. Growth continues to be driven by our power brands, which grew 5% with 4% coming from volume. These brands represent 78% of our turnover and remain our primary growth engine. The rest of our portfolio grew at a lower rate due to a few specific factors. In foods, commodity deflation weighed in on our tea brands in India. In beauty and personal care, we are prioritizing investments behind brands with strong momentum while reducing support for the tail brands. Pricing in the quarter was 0.9%. This reflects the carrier impact of price reductions in home care, notably in Brazil and in liquids in India. tea deflation in India, and the increased in-store activation and shelf investment in personal care linked to our FIFA World Cup activations. Importantly, our competitive position remains stable in both value and volume terms. As we look ahead and given the commodity cost environment, we expect pricing to play a bigger role as the year progresses, particularly in the second half. Beauty and well-being delivered 3.6% underlying sales growth with 1.9% from volume and 1.6% from price, driven by a solid performance across the beauty portfolio. Hair delivered high single-digit growth, led by double-digit growth in Dove Hair and K18. with premium innovations such as Dove UV repair and Glow bringing advanced protection against UV damage. We also saw improving performance in Salsilk and Clear, with growth becoming more balanced across markets. Skin grew low single digit with strong growth in Vaseline, supported by the Proderma body range. This was complemented by the continued momentum in Dermalogica and Tatcha, partially offset by a weaker performance in local brands. Wellbeing declined low single digit, reflecting a very strong quarter one comparator of over 23%. OLLI delivered double digit growth supported by digital commerce momentum and distribution gains. We expect performance to improve from quarter two, driven by liquid IV and neutrophil, as the campaigns to drive multiple usage occasions and attract new consumers gain traction. Personal care delivered 3.7% underlying sales growth, with 1.1% from volume and 2.5% from price, with volume showing sequential improvement. Dove continued to lead growth, delivering double-digit growth in deodorants and high single-digit growth in skin cleansing. At a category level, deodorants and skin cleansing both delivered mid-single-digit growth, supported by a strong performance in North America. In deodorants, growth was broad-based, with sequential improvement in Rexona and Axe, including early signs of recovery in Brazil. Skin cleansing growth was supported by the continued rollout of premium innovations, such as Dove Serum Oils Body Wash, with strong performance in emerging markets. Oral care was flat, with growth in Asia-Pacific Africa offset by softer performance in Europe. We are excited by our FIFA World Cup 2026 platform, activations and the campaign. These will scale in the coming quarters and amplify the growth momentum, particularly in deodorants. Home care delivered 6.1% underlying sales growth, with 6.2% from volume and price being broadly flat, reflecting the strong volume-led growth by emerging markets. Brazil delivered double-digit volume growth, while India delivered high single-digit volume growth with double-digit growth in liquids and record market share in powders. At a category level, fabric cleaning and fabric enhancers both delivered mid-single-digit growth, led by our premium portfolio. In fabric cleaning, we delivered double-digit growth in liquids, supported by the rollout of new Wonder Wash variants alongside a return to growth in powders. Wonder Wash is now available in 41 countries. Fabric enhancers continue to benefit from the strength of comfort. Home and hygiene also delivered mid-single-digit growth, with SIF continuing to perform strongly, and this was supported by the launch of SIF Infinite Clean Anti-Bac. Looking ahead, given commodity pressures, we expect more balance between volume and price in the coming quarters. Foods delivered underlying sales growth of 2.2% with 2.4% from volume and price being slightly negative, reflecting volume-led growth across both retail and food service. Hellmann's delivered mid-single-digit volume growth, supported by the continued success of the premium flavor-led innovations and strong execution across markets. Performance was particularly strong in Brazil, supported by the NBA campaign, and in the UK with the launch of the new Ranch range. Cooking aids delivered low single-digit growth with strong performance in Asia-Pacific Africa, partly offset by softer conditions in developed markets, notably Europe. Unilever food solutions also grew low single-digit, supported by improving trends in away-from-home consumption, particularly in China, its largest market. We'll continue to step up innovation and sharpen execution to sustain and strengthen our competitive growth. Emerging markets delivered strong broad-based growth with improving momentum across key markets. Asia-Pacific Africa delivered 5.9% underlying sales growth with five from volume, reflecting broad-based performance and improving competitiveness across markets. Over the last three quarters, on an average, we have delivered volume-led growth of around 6%. India accelerated to 7% with 6% volume growth, continuing the improving momentum seen over recent quarters. Growth was broad-based, with home care and beauty and well-being performing strongly and solid delivery across the rest of the portfolio. Importantly, this is not driven by a single category or any short-term factors. It reflects the progress we are making on sharper portfolio choices, fewer bigger growth bets, and improved execution across channels, with higher growth segments and premium parts of the portfolio contributing disproportionately to this performance. We are also seeing continued progress in the newer channels and demand drivers, including e-commerce and modern trade, which are growing ahead of the core business and supporting the overall mix. In China, we delivered another quarter of mid-single-digit growth in what remains a highly competitive market environment with differentiated growth across channels. Performance was driven by beauty and well-being and personal care, and supported by premium innovations, improved go-to-market execution, and continued progress in social and digital channels. We are seeing improving competitiveness, particularly in our power brands. Indonesia delivered solid growth of 4%, which reflects a clear improvement in the trajectory of the business following the reset. We are now seeing a return to more sustainable growth levels, supported by improved execution across channels, stronger innovation pipelines, and better activation in both traditional and modern trade. Importantly, market shares have now stabilized, with around half the business now gaining shares, reflecting progress from the actions taken, although there is still more to do to fully restore competitiveness. We're also seeing strong growth in the newer channels, including health and beauty and e-commerce, which are growing ahead of the core business and contributing well to the overall momentum. The Middle East represents around 2% of our turnover, and our operations in the region remain intact in quarter one with no material disruption to supply. Our priority remains the safety of our teams working in the region. More broadly, we have built a highly localized and flexible supply chain, which together with the inventory covers has enabled us to manage the situation effectively to date. We continue to monitor and take proactive actions in what remains a volatile environment. Turning to Latin America, we delivered 6.2% underlying sales growth, with solid volume growth of 2.6%, alongside 3.5% pricing, reflecting a clear improvement in the momentum across the region. This was supported by strong volume performance Brazil laundry, following the corrective pricing actions, and in Mexico, personal care driven by operational improvements. Beauty and well-being delivered double-digit growth and good performance across key markets. Developed markets delivered a mixed performance in the quarter. North America delivered resilient performance in soft market with 2.1% growth driven by 2.2% volume, while price was slightly negative. This reflects the strength of our execution and the competitiveness of our portfolio with continued momentum in power brands. Growth was led by personal care, which delivered mid-single-digit growth with strong volume momentum in deodorants and skin cleansing, underpinned by the continued strength in Dove and our premium innovations. In beauty and well-being, volume-led growth in skin care and hair care was offset by well-being, which declined against a very strong prior year comparator. In foods, performance was flat overall, with Hellmann's continuing to deliver good volume-led growth. In Europe, underlying sales declined 0.9%, with a 1.2% decline in volume and a 0.3% growth from price. Performance reflects a soft market environment across categories, with consumer demand remaining subdued. Within that, premium innovation supported growth in categories such as laundry, deodorants and condiments. Our largest category, cooking aids, declined in low single-digit in line with market conditions. Turnover for the quarter was 12.6 billion euros, down 3.3% year-on-year. Underlying growth of 3.8% was more than offset by currency headwinds, with FX reducing the reported turnover by 7.7%. Given that currency devaluation was more pronounced in the second half of 2025, the base effect should ease as the year progresses. And based on the April spot rates, we expect the full-year currency impact on the turnover to be lower at around minus 3%. Portfolio changes contributed to a net positive 0.9%, with acquisitions adding 1.4%, reflecting the strong performances of Dr. Squatch, Wild, and Minimalist, and this was partly offset by a 0.5% impact from disposals primarily relating to foods and the tea business in Indonesia. Our full year outlook remains unchanged. We expect underlying sales growth for the full year, 2026, to be at the bottom end of our multi-year guidance range of 4-6%, with at least 2% underlying volume growth for the full year. On margin, we expect a modest improvement versus last year, with broadly similar absolute margin levels between the first and second halves. The margins are supported by volume growth, mix improvement, continued savings, and benefits from our productivity program, which continues to run ahead of the schedule and has already delivered 750 million euros by the end of quarter one. We will maintain competitive and healthy levels of brand investment. Given the current environment, there are a number of moving parts, particularly around input costs, pricing, and market conditions, and we'll continue to manage these with discipline. On capital returns, today we have initiated a €1.5 billion share buyback, and we expect to complete the program towards the end of the first half. We remain committed to sustained, attractive and growing dividends. Our medium-term leverage target remains around two times. We expect to be below two times immediately following the separation of foods. With that, over to you, Fernando.

Thank you, Srini. Let me come back now to the broader steps we are taking to build a simpler, sharper, faster Unilever. At the highest level, there are three things we are doing, and they are very much interconnected. First, elevating our brands to outperform markets in volume growth. Second, stepping up operational excellence across all our geographies. And third, taking decisive portfolio actions to unlock value. Let me start with the first, desired scale. This is the model we are using to elevate the quality, relevance, and the reach of our brands. And it is, without question, the single biggest driver of the improvement we are seeing in the admissible brand superiority scores of our portfolio and in the volume growth rate of our power brands. Desired Scale is built around a very clear, simple framework, what we call SASE brands. It is about brands that are rooted in superior science, with top-notch aesthetics and visibility, and with truly compelling sensorials. Brands that are talked about, recommended by many to many, and that are culturally relevant. Simple, clear, effective. You can see this very clearly in brands like DAF and Vaseline. DAB is now close to a 7 billion euro brand and it has delivered more than 6% growth for 14 consecutive quarters. Over the last five years, it has added around 2 billion euros of incremental turnover. And that is coming from a step change in product superiority combined with a completely different model of consumer engagement. with more than 100,000 creators actively working with the brand. Ortei Vaseline, a 150-year-old brand that we have fundamentally transformed. It has been delivering double-digit growth over the last five years. And by combining superior science with cultural relevance, it is now building real momentum with younger consumers. For example, delivering more than 100% growth in TikTok shop in Southeast Asia. a demonstration of bustling strengths in social commerce at scale. The second element is operational excellence, because desire at scale only works if it is supported by flawless execution. This is about how we create categories and how we execute in the market together with our customers, understanding consumers better, activating brilliantly, and executing perfectly in-store, both offline and online. Again, we have a growing number of great examples, like the Redwood and Wonderwash, an innovation anchor in superior science, already at around 200 million euros of annualized turnover. By redefining the category to short wash cycles, Wonderwash is strengthening our position in the fast-growing liquid segment of laundry and scaling up at speed. Or Hellman's, Flavor Mayo, that is now in 35 markets and has already reached 100 million of annualized turnover. Different brands, different categories, different geographies, all benefiting from a common marketing philosophy rooted in what consumers expect and demand of brands today. Brands that are creative and dynamic reflection of the present and not a tired representation of the past. Let me turn now to the third element, the portfolio. Here, we are taking decisive action to unlock value through the separation of foods and its combination with McCormick. And we are doing this from a position of strength, fully aligned with the strategy we have been executing. The transaction we have announced creates two businesses with improved growth profiles. First, a simpler and more focused Unilever, a pure play HPC business. A business with a very coherent portfolio, where around 90% of the turnover is in number one or number two positions, and with a proven ability to deliver top-tier volume growth and top-tier return on invested capital. Given relative valuation and relative in-market performance to peers, we see clear valuation upside here. Second, a highly distinctive foods business, a scaled global flavor powerhouse with iconic brands and leading positions in attractive segments of the foods market and with significant revenue growth potential. There is a clear strategic fit between Unilever Foods and McCormick, centered around complementary geographical footprints, a stronger presence in retail, a scale business across food service channels, and leading science and research and development capabilities focused exclusively on flavor. It is for all these reasons I am referring to this as a growth-led separation of our foods business. One that will give shareholders the same level of exposure to foods, but with much higher quality and more optionality than they have today. We know that this is a significant change and that it has to be delivered flawlessly. We are confident that it will. We have proven experience in separations, most recently with ice cream. Our experience confirms our ability to separate the business of scale while delivering top-line growth, volume, and margin progression. And the transitional service agreements will ensure continuity while providing the time needed to remove stranded costs before they impact the P&L. We already have dedicated teams in place working closely and collaboratively alongside McCormick, who themselves have a strong integration track record. All work streams to separate foods from Unilever and integrate the business into McCormick are now in motion. We are moving fast. With that, let me briefly sum up after what has been a positive start to 2026 for Unilever. It was a quarter in which we once again demonstrated our ability to both perform and transform. Performance comes in the shape of superior volume-led growth, our single biggest priority, driven by our power brands and by one of the most distinctive Unilever assets, its strength in emerging markets. Underpinning this positive start to the year, it is a further step up in operational discipline, something which becomes even more important in light of the current heightened macroeconomic uncertainties. We will manage the business in a more volatile cost environment, focusing on volume growth, price competitiveness, and discipline management of every single line of the P&L. We will emphasize the drivers of demand that have the highest return in the current context. We are confident in our delivery and we are reasserting our full year outlook for 2026. We have taken a decisive action to transform our future portfolio and we have done it from a position of strength and driven by a growth mindset. Our organization today is stronger. Our portfolio is sharper. Our priorities are clearer. And desired scale is breathing new life into our power brands and our whole marketing. We are now capitalizing on these developments with much more discipline in market execution. And wherever we have made decisive interventions, like Indonesia, China, or more recently, Brazil, positive results are showing up. To go through these changes in more depth, we look forward to hosting a Capital Markets Day on 4th of November, when we will go deeper into how we will capitalize on our new, sharper, fully focused home and personal care pure play. One that is aligned to higher growth categories, faster growing geographies, more premium segments, and a superior route to market. For now, thank you for listening. We look forward to taking your questions.

Many thanks for joining the call. If you would like to ask a question, please press star followed by one on your keypad. If you no longer wish to ask a question, please press star two to exit the queue. When it is your turn to ask a question, your name will be called out. And finally, please keep your questions to a maximum of two.

Thank you very much for joining the call. Our first question comes from Warren at Barclays. Go ahead, Warren.

Yeah, good morning, Fernando, Trini and Gemma. Warren here. So I've got one housekeeping just to clarify. Did you say that North America would accelerate from here? It was a bit quick, so you can just clarify that. And then my two questions are, firstly, Fernando, on emerging markets, are you able to talk about how you feel about the four big engines? of Brazil, India, China, and Indonesia as we look into Q2 in the second half. Any signs of a slowdown also in Southeast Asia? So the EM outlook from here, you've obviously got easy comps in some places like LATAM. And then secondly, Trini, on the margin guidance with higher oil, are you able to give us an NMI number? And how much scope do you have to push productivity savings and or pricing to make sure that you are indeed able to deliver the margin guide despite higher oil. Thank you.

Cool. Thank you, Warren. I will cover the geographical part and Shane will cover the cost one. Well, let me start saying that we are pleased with our good start to the year. You know, 3.8% UAG, 2.9% in volume, power brands at 4% UAG, DAF, our largest brand, at 7% UAG. And we have seen also a strong start to quarter two, despite all the uncertainties that are very obvious to everyone in terms of geopolitical and macroeconomic environment. So momentum continues in the business. Regarding emerging markets, You know, as I mentioned this many, many times, but our strength in emerging markets is definitely a longer competitive advantage, given the exposure it gives us to better population growth rate, wealth margin expansion. And we know this gap versus developed markets are reducing versus the past, but it remains significant, you know, and And the resilience of our portfolio in emerging markets is a particular advantage when you have to drive the business in conditions of significant volatility. Regarding the specific regions you mentioned, in Latin America, our performance is accelerating. We deliver more than 6% and rise in growth in the quarter. Foods and beauty and well-being keep performing strongly, as they did in 2025. But we are also starting to see the impact of the decisive actions we have taken in both laundry and deodorants, particularly in Brazil. In Brazil, we deliver double-digit growth in laundry. Two reasons for that, the successful introduction of Wonder Wash in the liquid segment, but also the return we are seeing for the correction in pricing that we have done to restore competitiveness in the powder segment that is the largest in the laundry categories. In deals also we are seeing momentum there. The aerosol format is recovering. This is crucial to boost market growth and also to boost our competitiveness. We are in early stages of that recovery. We see this will accelerate in quarter two with the fifth activation that we will have. and with the setup of the new planograms that we have done in partnership with our retailers. India, Shini can cover in more detail, but a strong broad-based performance, 9% growth in home care, 8% in beauty, 5% both in personal care and foods. India, Shini can cover a bit more on that. China, return to mid-single-digit growth. We are very pleased with the improvements in food service, particularly in China. We are seeing the out-of-home channel in China picking up, and that's very important for our most important food service business, that is the one in China. And Indonesia, run-raise continue improving. It's the fifth consecutive quarter with run-raise improving. We deliver 4% growth. That is much more sustainable. Of course, we have had in the second half of last year very low comparators there, but performance is good. In U.S., as you know, we have delivered 4% volume growth in North America in the last three years. It has been a very consistent performance despite tough markets. Probably has been one of the best performances in the sector. And we believe this performance is a reflection of the profound transformation we have done to our portfolio. And, you know, we are seeing also significant improvement in our relationship with customers, I have mentioned before. that in the Advantage survey we have ranked number one in PC and foods number three in beauty. But recently we have received the Consumable Supplier of the Year Award and the Excellence in Assortment Award from the largest U.S. retailer. This is another evidence that our partnership with retailers in the U.S. is really going from strength to strength. Quarter one was softer at 2.1% USG. All came from volume. Performance in personal care was strong. Great performance in Dabhair and 3M styling. But the quarter was affected by weak performance in foods and well-being. Well-being had very, very strong comparators, more than 20% in the same quarter last year, more than 40% in liquid IVs. But we remain very, very confident of the structural growth potential of the well-being verticals. And we see well-being firmly back into growth in U.S. in quarter two. There are a couple of brands that we need to fix in U.S., particularly Nexus and Shane Mosher in healthcare. But we see our performance in U.S. accelerating from quarter two onwards. Shini?

Yeah, thanks, Fernando. Thanks, Warren. I'll cover it in two parts. First, I'll talk a bit about India. Then I'll go on to commodity inflation and how we're going to manage that. I think the point Fernando made is the right one. The quality of performance in India has been of a very high order. It's just not the headline number, but it's across the breadth of the performance, which is broad-based. Giving you some color, let's say when we look at it from a home care perspective, while growth was at 9%, what is really impressive is that in liquids, we have grown double-digit. That's really leading the market development. And in powders, we've actually hit record shares. That's on that. If I really talk about, let's say, beauty and well-being, the strong momentum in hair continues, and we are making very clear choices and investments between quick commerce, e-commerce, and broader omni-channel. The pricing actions along with the GST have started to spur growth in this. Even the new age brands such as minimalist are performing quite well in the market, and that's giving us a lot of confidence in this segment. Personal care growth was at 5%, but strong step up in the premium segments, which is including dove and pears. And for example, in a market development opportunities that has body washes, we have actually gained about 400 basis points of share, which again starts to step up well into the future. And last element, when you think from a foods perspective, we've also seen a bit of an uptick, actually an improvement in Horlicks with all the actions we have taken. While there is some deflation in tea, but overall from a volume and a value perspective, the foods business is looking good. This is all aligned to the strategic progress that we made across the four pillars of segmenting consumers, making our brands desirable, accelerating the frontline capabilities, and making fewer and bigger bets. Just to add a couple of elements, we have put in a new organization to really address our quick commerce and e-commerce and omnichannel capability that is functioning well. From a general trade perspective, we have increased the outlet coverage by about 200,000 outlets, which takes us to about 2.3 million. And the India operating model is actually enabling us to drive execution and agility. It's also important to highlight one element from an India context. While there is inflation, and there will be both from an imported crude as well as currency, it's important to highlight that classically in a category such as home care, this actually works in our favor. We have the portfolio to cater to the different price points through brands. But more importantly, a lot of the local players get constrained both from a supply perspective as well as cash. So you have the unique opportunity and the ability to actually manage the right price and volume equation in India and continue to keep the growth momentum going. So therefore, from a broad demand outlook perspective, India is looking good and we are quite confident in terms of our ability to continue to keep the growth momentum. Now, coming to the question on costs and commodity, I will take a little bit of time to explain this. I do appreciate that it's on everyone's mind. First and foremost, we want to reiterate that there is no change to the Unilever value creation model. Our model is built on volume-led growths, premiumization and mix, driving gross margins to invest behind our brands, and keeping a very tight discipline in terms of the costs. While you all know we have made significant progress in the past few years in terms of our gross margin expansion, upwards of 400 basis points, we've also increased our investments behind our brands from about 13% to 16%, and we have continued to drive a model which works for us on a multi-year basis. If I just give a bit of a context to 2025, Again, it's important to see last year, we had reasonable amount of commodity inflation, but a significant pressure for coming from currencies. From an EPS or an earnings perspective, the currency drag last year was as high as 8.8%. When you contrast it to this year, Given the commodity outlook, we will expect commodity inflation to be higher. But from a currency perspective, this year, we definitely see that it's going to be much better. Even when you see when we've called out in the earnings call, We expect that the impact of Forex on our top line should be more normalized to 3%. And if you contrast it to last year, that was 6%. So the key essence of the message here is while we will see inflation from a commodity, currency at an aggregate will really be, from the information we have, favorable for us. Now, coming to the inflation, of course, the Middle East crisis has created uncertainties and has made the outlook a bit challenging. Inflation for us is just not one number. While there is crude and everyone really anchors around crude, It is complex because there are many crude link derivatives. There is Forex, there are elements of supply chain costs, wage inflation and others. So at a commodity level, there are elements which then start to play out differently. Our expectation for the full year inflation is in the range of about 750 million to 900 million. This is the total inflation. This is just not material inflation, but also the non-material costs, including logistics and our factory operations. If you were to put it into context, this will be about 350 million to 500 million higher than our prior expectations when we began the year. Our working assumption for all these costs is really crude at around 100. While we are all looking at a spot crude, which is today's context of 124 or yesterday's 110, it's also important to highlight that when you really look at the futures, quarter three futures are still at 100 and quarter four futures are at about 90. On a balance, therefore, what we have done is to really take 100 as a working assumption in our guide, and on that basis, we have said that we will continue to deliver a modest margin expansion. Couple of other elements to highlight in this. because that becomes very important. When we really see it from a category perspective, when you see beauty and well-being and personal care, the aggregate levels of inflation that we see in 2025 are not materially different, in 2026, are not materially different to what we experienced in the prior year. And in the prior year, we have managed both the volume and the pricing extremely well in these two business groups. The place where we will see heightened inflation, actually 50% of the total net inflation for us is coming through in home care, and 70% of that is actually focused around the emerging markets. we are deploying the full range of mitigation opportunities, competitive buying, commodity covers, formulation flexibility, packaging interventions, SKU focus, and productivity across the value chain, and a complete and a very tight control over the discretionary costs. At this levels of inflation, we do recognize while we will drive all of this, it will not be possible, it may not be possible for us to just cover it from the cost action, so we will take pricing. Pricing will be needed in selected markets and categories, notably home care. It will be calibrated and it will be done in a competitive manner. Our priority will be to really protect the consumer value while also taking care of our financial model. On this point, again, it's good to repeat that in emerging markets, given the strength of our portfolio, our ability to be judicious in the way we manage pricing we will have levers to manage it in a sensible manner is a good point. Just last two points to complete the picture on this. On brand investments, we will continue to invest behind our brands at competitive levels to sustain the growth momentum. we always said that our competitive spends will be classically in the range of 15 to 16 percent and therefore we are not going back to an era of under investing but we will ensure that the spend is deployed effectively and in the right channels from an overheads perspective you have seen that we have already delivered 750 million so almost 80 million incremental savings in quarter one We are more than confident that we will complete the 800 million program in the next quarter. And given the various series of measures that we have taken to manage costs, we will drive this harder and deliver higher savings. So in an essence, in this range of 750 to 900 million, we are comfortable to say that we can manage competitive growth, deliver on our guide of four to 6% and drive modest margin expansion.

Thank you. Our next question comes from Celine at JP Morgan. Go ahead, Celine.

Yes. Good morning, everyone. So my first question is on the balance of growth for the year. So you reiterated your guidance to be at the low end of four to six. And I understand that price mix will be more balanced in home care as we go through the year. Can you talk about, you know, first of all, that volume will be above 2% for the year. And when we look at your two category, beauty and personal care, volume was below, in fact, that 2%. Should we fairly expect that this will be in the range of two each for the year? And what would drive that acceleration in the second half? And then my second question is coming back on maybe well-being. You said it was down low single digits. Is it possible to understand how was it U.S. versus the rest of the world? What's happening in the rest of the world in terms of your white space opportunity? And in the U.S., if you could go a bit deeper in understanding that. neutral flow and liquid IV performance and the go forward. Thank you.

Yeah. Thank you, Celine. Yeah, we are confident in delivery of 2% volume growth. If you look at the last nine quarters, 24-25 and quarter 1-26, our average volume growth has been 2.5%. And we had a good start to the year with 2.9% in the first quarter. And as I mentioned before, we have a good start of the quarter too. I feel the key point to say, this is the result of brand equities that are strengthening. More than 60% of our revenue is increasing what we call a miserable brand superiority score. We have a great innovation plan, one of the best that we have had in years, hitting the markets now. And we have one of the strongest activation platforms in years with the personal care sponsorship of So this gives us real, real confidence that we will deliver volume growth for the year above 2%. Turnover weighted market volume growth is in the territory of 1%, so this clearly shows our performance of the markets when it comes to volume growth. We expect pricing to accelerate along the year, so we expect the H1, our growth, to be led by volume. We expect better balance between volume and price in the second half of the year. And when it comes to beauty and well-being, basically, we deliver 3.6% in quarter one. Our beauty business performed really strongly, but well-being was diluted for the first time since we entered the category. We have a great quarter in hair care with high single digit growth and we have a great quarter in prestige where we grew 10%. Strong results across every single period of prestige in skin, in hair and in color cosmetics, particularly at the highest end of pricing. Brands like Tatcha, Hourglass and K18 really performing very, very well. Regarding well-being, we declined 2%. Our well-being business continues being fundamentally anchored in the U.S., so the international business grew nicely, but it doesn't change the overall numbers of well-being. Oli grew 18% in the quarter. But we have some issues in Liquida B and Nutrafol that we have to sort out. In Liquida B, we lapped a comparator of more than 40% growth last year. There was a different facing in the shipments prior to the summer season in U.S., We continue seeing solid growth in the powder hydration market, but our share has been a bit under pressure due to a new wave of market entrants that has reduced our share of assortment in the category. We have seen this many, many times before since we acquired Liquid IV in 2020. Hundreds of new brands entering the category, but very few can sustain velocity after some period of time. Liquid IV is four times the size of the second player in the category. We are reinforcing our plans to regain share and we are very, very confident that we will have a strong quarter two for Liquid IV. In the case of Nutrafol, the brand continues having exceptional levels of retention. I have never seen anything like that in any brand I have worked in my career. but we need to address the issue of a significant increase in the cost of acquiring new customers. We have seen particularly telehealth platforms in the U.S. significantly investing in the cross-selling of GLP-1 injectables and hair fall products, most of them with significant negative side effects. We are addressing this. We are highlighting the clinical superiority and the no side effects of Nutrafol, and we expect in the case of Nutrafol the results to become better in the second half of the year. The brand was flattish in quarter one.

Thank you. Our next question comes from Nicolas at Bank of America. Go ahead, Nicolas.

Good morning. Thank you. Two questions for me, please. The first one is coming back on the pricing element. Are you pricing enough in Asia-Pac, Africa? I see your pricing is around 1% and the FX is down 10%. Do you think that kind of gap is sustainable or do you expect that to close in the future? And then just if you could talk a bit about Dr. Squatch. We've seen a lot of slowdown in scanner data. So if you could just update us on whether you think that brand is still on track to achieve their business case. Thank you.

Let me start by Dr. Squash and then Shrini will cover pricing. Hey, good performance overall of Dr. Squash. You know, we are seeing significant growth in body shower and in deodorants in particular. We see some slowdown in the Dr. Squash bar segment. But, you know, we expect Dr. Squash will be part of our underlying sales growth from September, if I'm not wrong. And we expect double-digit growth in Dr. Squash going forward. So we have been delisting some items that we didn't think were fundamental for the brand growing forward. This is affecting some of the share reading. But in the core of Dr. Squash, the performance is strong. And we see this as a strong contributor to our growth from September onwards in the U.S. market. Shini?

So from a pricing perspective, what you will see is that it's important to say that you will start to see a step up in the pricing. Quarter one low pricing also gets explained by what's happening in a few of our categories. For example, if you see in the case of India, we had deflation in T, and therefore that has played out. That does not impact the value creation in the model there. In the last year, we'd also taken pricing corrections in our liquids part of the portfolio, which actually anniversarize in quarter one. So in that sense, what you see in the quarter one is the lowest point of it. We've already initiated price increases, and that's coming through right from quarter one to quarter two. We'll start to see the benefit going forward. In case of home care, at a broader level, it also impacts some of the, I'm also giving you a broader question on pricing. This also reflects some of the actions which took in Brazil and Latin America, which actually will then start to anniversarize again in a matter of one more quarter. So broadly speaking, from a pricing perspective, what you see is a reflection of the fag end of some of the actions which we have taken in the prior year and which have given us benefits. Going forward, we are pricing up on a sensible and a competitive manner to while cover commodity when it comes to the commodity linked categories and linked to innovations in beauty and well-being. And therefore, you will start to see a step up on pricing right from quarter two. And as Fernando has alluded to see, you will see a better mix of it and it will improve progressively as we go into half two.

Let me add something, because I feel I have mentioned this before, but I want to repeat it to be clear. The times of being uncompetitive in Unilever in any driver of demand are gone. And we will manage the business in a more volatile cost environment, focusing on volume growth, on price competitiveness, and a disciplined management of every single line of the P&L. We will emphasize the drivers of demand. that have the highest return in the current context and ensure competitiveness in both pricing and brand marketing investment. With the assumptions that Jimmy has made in terms of the oil price that we see and the impact that we have in cost inflation, despite this, we continue to see the possibility of increasing our operating margin in modest terms as we have highlighted in our guidance.

Thank you. Our next question comes from Jeff at BNP. Go ahead, Jeff.

Sorry, apologies for that. Can you hear me?

Yes. Yes.

OK, two questions, if I may. You know, when you move into a more inflationary environment, you know, historically, like the likes of those started to accelerate. So why are you still guiding to the bottom end of the four to six? because obviously the inflationary backdrop is rather different to what it was at the start of the year when you initially set the guide. That's the first question. And the second question is, we've heard one of your notable peers talking about some suspicion that there may have been a degree of retailer stocking ahead of expected price increases. I'm just wondering if you've seen any evidence of that, particularly in the emerging markets business. Thank you.

Thank you, Jeff. I will cover the second part, and Sini can cover the inflationary environment and the guidance. No, we have not seen any significant stocking. There have been a few countries, you know, the east are facing has been different, but You know, at the same time, as I mentioned before, in the case of liquid IV, particularly in the U.S., our facing has a bias in the quarter, too. So, in terms of retailers stocking in anticipation of price increases, we have not seen anything of material impact at all. So, nothing in that space. On inflation and pricing...

I think two important points, Jeff. Obviously, we are going to ensure competitiveness, both volume and price. And for the dynamics that I've explained that look both from a beauty point of view and personal care point of view, the inflation levels are in the ballpark of what we handled last year. So when we take these into account, yes, it actually gives us the confidence to say that we will be able to deliver our 2% volume as well as the 4% to 6% top line. However, what we're also conscious and cognizant is that the levels of inflation which are coming through, and it's just not on a sector alone, what we are likely to see that there could be a potential larger impact on consumer and consumer sentiment. And the way inflation is going to land, given the dynamics, it could also be different in different parts of the world. So we will require to have some more visibility in terms of how consumer demand is playing out. We need to have some more visibility in terms of how some of the buying patterns are playing out. Therefore, it'll be prudent for us to actually come back and revisit the guide at half. So at this stage, what we have therefore said on a prudent basis is to ensure that we give confidence to the markets that we still will deliver our four to six, and we will come back with a better read in a quarter's time, and then we could actually have a conversation in the full year.

I would like to reinforce. In the last earning call, I mentioned that we firmly believe that in the long run, our combined category and geographical footprint offer around 2% market volume growth and around 2% to 3% pricing. At that time, you told me that the 2% pricing looked very far. The situation has changed now. But this is what we have seen in the last decade or so. We expect the same to play out in the long run. And as you know, most of the impact in pricing this year will be in the second half. So we are cautious at this stage. And as Trini mentioned, we will revise this when it comes to second quarter results.

Thank you. Our next question comes from James at RBC. Go ahead, James.

Thank you, Gemma. You're presenting your updated remuneration policy to AGM in a couple of weeks' time. What's the thinking behind the annual bonus and performance share plan kicking in for sales growth well below your 46% guidance?

Yeah. Yeah, we are presenting the remuneration policy in the next AGM. That is the 13th of May. There is a clear intention of becoming competitive with global companies in that space when it comes to remuneration. And when it comes to the targets that we put at the beginning of the year for our annual bonus, it reflected the market conditions and it reflected what top TSR performance implied. As we mentioned before, the situation now has changed in terms of what is the potential inflationary context in which we are working. But we present the targets on an annual basis, and we will change that if next year the conditions are different for the PSP and for the annual bonus.

Maybe just one additional element to add on that. The key is really the long-term incentives. And actually a couple of the measures in the long-term incentives are completely actually bulk of the remuneration there is linked to shareholder return and outperformance. So 30% of the weighting in the long-term incentive continues to be on TSR. Therefore, that takes into account any of these changes. Second, if you actually again look at it from a return on invested capital, that's again a long-term measure which is again linked to competitive outperformance. So in some ways... I don't believe that that materially changes. Anything that is coming in the remuneration policy is linked to shareholder return.

Thank you. Our next question comes from Olivier at Goldman Sachs. Go ahead, Olivier.

Thank you, Gemma. Good morning, Fernando. Two questions. First, you mentioned previously that 50% of inflation is in home care. Can you perhaps comment on the magnitude of the price increase in home care you would need to take to offset the current input cost inflation that you're seeing and regarding other divisions like personal care as well should we expect a price increase and then secondly it might be a little bit of a technical one but uh notice that the share buyback is still one and a half billion the same amounts but it's going to be done by july 6th that's going to be done over the next 45 working days Last year it was done seven months, but it was more like 70 plus working there. So any rationale for this increase in speed? Thank you.

Well, share by back acceleration, you know, it's very clear that the markets have suffered in terms of valuation, and we are very confident in the future valuation of the company, even our performance. You know, we really believe that the unilever that we are shaping, as we mentioned when we announced the McCormick transaction, is one that has been bottom quartile in valuation with top quartile in performance. So this is a good moment to measure buybacks, and it's a good moment to measure buybacks in an accelerated way. Regarding Middle East conflict, I would like to highlight a couple of things. First of all, Middle East represents for us around 2% of the revenue, and until now we have not seen any material impact in consumption level or disruptions in the operations. Of course, the closure of the Hormuz Strait may have potential implications in terms of availability of petrochemical materials, But this can be an opportunity for us because we have a very resilient supply chain, a multipolar supply chain with multiple sources of materials, and this resilience can imply a competitive advantage. We see growth opportunity in laundry powders because we see local players, particularly in India and Southeast Asia, being affected in terms of availability of materials. Xinyi, you want to comment on inflation in Hong Kong?

So just a couple of things. It is home care and a lot of that of the total inflation, 70% is in emerging markets, which therefore is an opportunity for us to actually be able to take up prices. Having said that, in line with our own experience and best practices and to ensure our competitiveness, We will lead pricing where we are leaders. We will follow where we are not. The price increases we will take will always be calibrated. There will be frequent price increases, but in small doses. That ensures that we get the right balance of giving value to the consumer while protecting our model. This could also mean that there could be a bit of a lag between when commodity starts to hit, when pricing starts to come in. Now, these are the elements which we'll have to continue to monitor and validate, and therefore, we will fine-tune. That's also the reason we talked about all the other measures which start becoming important for us to manage the P&L, from formulation to logistics to manufacturing costs. And that's the only reason at this stage, yes, we should expect pricing to be higher. but it's not going to be a one-to-one correlation. And for that reason, we will not be able to give you a specific guide today. We could have a better conversation in three months' time when we have better clarity of the environment and overall consumer demand.

And Olivier, I would like to highlight something that Srini mentioned in the beginning of the call because the situation is different in different markets. Very, very differently to previous global crises we have seen, we are seeing emerging market currencies holding relatively well. If you take a market like Brazil, for the moment, we have seen an appreciation of the currency that is higher than the increasing material costs that we are having. So I feel the situation is very different for different home care businesses depending on the geographies in which we are operating.

Thank you. Our next question comes from Callum at Bernstein. Go ahead, Callum.

Great, thank you very much. Just to start, coming back to home care, please. The 6% volume growth is obviously quite remarkable. Reading your commentary, it seems like it's quite broad-based across fabric cleaning enhancers and hygiene. Maybe you could just add some color for us, please, on what are the drivers of that 6%? How much is market growth versus your share gain? What are your share gains being driven by? And are there any one-off factors in the plus six that we should be cognizant of? And then my second is actually unusually coming back to remuneration. You had some very interesting commentary and examples in the annual report about your ability or probably I should say inability to attract talent especially in the US, where it seems like your compensation is just not market competitive. So my question is, how are you and the board thinking about this, given the strategic focus on growth in the US market, and could there be pressures on margins if you need to structurally improve your compensation packages? Thank you.

Thank you, Callum. Regarding home care, our comparator was relatively low in home care, but I feel what is important to highlight that on a two-year basis, you know, we have been delivering consistently volume growth in home care above 3%, you know. And this is a combination of a solid performance in fabric cleaning and I would say a stellar performance in home and hygiene and fabric enhancers, you know. I feel SIF grew this quarter around 15%, domestic high single digit. As Srini mentioned, in the case of India, we achieved the highest ever share in laundry powders. We are increasing our position in liquids strongly. We have had double-digit volume growth in Brazil, in fabric cleaning, in Vietnam, in Arabia, in Turkey, high single-digit growth in Argentina. So there is a broad-based, very, very strong growth. And I believe it's a combination of really restoring our pricing competitiveness in powder and at the same time accelerating the growth market development of liquids with a special role for the Wonder Wash that is already more than 200 million euros in annualized sales and is already present in 41 countries. So overall, broad-based, good performance in home care. We see momentum in the business and we see momentum in the three pillars of home care, in fabric cleaning, in home packaging. and in fabric enhancers. Probably the one that is a bit slower that is growing at around 5% is dishwash that is more exposed to Southeast Asia and does grow the category in which we have seen a bit less dynamism. In terms of remuneration, it's true. As you know, we have been looking at appointing some top leaders in the organization from the outside. This is a very different Unilever in which the combination of born and bred talent and talent info from the outside is much more balanced than in the past. We are increasing our exposure to the U.S. and we are allocating significant capital into the U.S. And it's very, very important that we are able to compete with American companies when it comes to remuneration. We don't believe that this has an impact at the global level in terms of our cost base, but we need to really increase the ceiling of remuneration in the company to be able to ensure that we can attract top-notch American talent, because at this stage and for many, many years, we have been lacking kind of leadership at the top of the organization coming from North America, and this has to change in the future.

Maybe one small clarification on the question related to any one-offs in home care and otherwise. At an aggregate Unilever, there is nothing specifically to be called out. Could there be some small pockets of people buying in? Possible. Did we have some adverse impact because of Eid timing? Slightly possible. So therefore, there are always some small ins and outs in a few places. But when we look at it in an aggregate, there is nothing that we would really call out as something to point out from a quarter perspective.

And I believe it's important also to highlight that our distributors covers, you know, are one of the minimums we have in history. So basically this is showing the efficiency of our model, our operational discipline, and also the care we are taking in ensuring that the working capital across the value chain is properly managed.

Thank you. Our next question comes from Carl at Kepler. Go ahead, Carl.

Yes, good morning. Thanks, Gemma. Two questions. The first one, now you already discussed market shares for a couple of individual markets and regions, but on an aggregate level, what have your market shares done over the last quarter? And then the other question is a follow-up on Latin America. You discussed Brazil, but what's the trajectory going forward? Because it's been quite volatile in 2025, but things seem to be getting better So what should we anticipate for LATAM as a region going forward? Cool.

Market share has been stable in the last few readings for us, you know, after significant gains that we have had around the first three quarters of 2025. Shini can give more color on that. Regarding Latin America, as I mentioned before, you know, we have delivered 6% growth in the quarter. We already in 2025 were having excellent performance in foods and beauty and well-being, but we have some issues in laundry and deodorants, particularly in Brazil. This has been corrected. You know, we see momentum in the business. The actions we have taken in deals are at an early stage, so we probably will see further acceleration in our personal care performance in Latin America. That is very important because deodorants in particular in Latin America is a big contributor to the growth of the total personal care business. So a lot of confidence in our development in Latin America going forward. I would say in Americas overall because we expect also North America to be better.

from quarter to long war so optimistic about it market share session so simple three simple messages both from a value as well as a volume shares perspective we are relatively stable i think that's actually quite encouraging just given the context of where we are it also is ensuring that we are in the right space both in terms of volume and our pricing in in the market so Point number two, we have seen some positive acceleration coming through in India, and that's understandable given the quality of the performance which has come. I think that positions us well. The other element to highlight is, again, when we see the last four weeks read in North America, we have seen a strong comeback in some of our categories, most notably in personal care. That, again, positions us well. So just a bit more color to the comment, but in aggregates, shares are stable both on value and volume terms.

And remember that we cover around two-thirds of our revenue in market share reading. You know, if you look at our 2.9% volume growth and you compare with markets growing around 1%, it's very clear that we are outperforming the market there.

Thanks. Our next question comes from David at Jefferies. Go ahead, David.

Thanks, Jeff. So two for me, just firstly on Thailand, I know not a big market, but we picked up that you lowered prices coming into April and apparently a reaction to the struggles on energy prices for the consumer. I think you explicitly made that point. So just wonder whether, is that something that you're having to do in other Asian markets? And is that something you're doing proactively or is there an element of government pressure in that market or other markets to be seen to be kind of helping consumers with the tougher environment? And the second question just came back to the home care dynamics. Pricing obviously been very low for the last nine quarters, up one or even negative for some of those quarters. So just to explain the dynamics there, is that the input costs were deflationary and that's what was allowing that pricing, or is it a competitive intensity dynamic? And then related to that and some of the moving parts you talked about, will home care margins you think be up this year, or is that an area where you have to sacrifice profitability given where the input costs lie and you make it up in other divisions? Thank you.

let me cover a couple of things and then home care margins really can take it a thailand is a very special situation you know thailand has entered into a conflict with cambodia around 10 to 15 percent of the volumes of the thailand market were flowing into cambodia that has been closed and fundamentally this has made some players in the market to really react with significant promotional investment And we have reacted to really ensure that our competitiveness was strong. So basically, it's a very, very peculiar situation. We have seen some international players in particular reducing prices significantly. And as I mentioned before, being uncompetitive in Unilever is not an option anymore. And we have reacted to that. In the case of home care, yes, the context of it has been deflationary for around, I would say, one year and a half. This is, of course, changing now, and we see prices in home care accelerating. We have been enjoying very, very solid growth margins in home care, and our operating margin has been increasing strongly. But you want to add some color on that?

So the additional color to that is that it's absolutely right that there has been deflationary with crude sitting at about 60, which had actually started tapering off from the mid-70s, and therefore that reflected in pricing. The other element, these are the corrections which we actually put in the first half of last year. That's when we addressed some of the places where we were not competitive or we had to react to ensure we were competitive, notably Brazil and India. We took those corrective actions. In all the markets that we operate today, we are on strategic pricing in home care. That positions us extremely well. And the way we have really articulated in terms of taking judicious pricing, calibrated pricing will position us well. Coming back to your question on overall home care margins, it will be our first endeavor to ensure that each business group really delivers on its financial model. But given the magnitude of some of the commodity inflation and the lead lag between pricing and commodity, if we need to really support home care and make it up in some other business groups and categories and cells in the short term, we will do it. But that's something that we will do in a sensible manner without impacting the competitiveness of any of the single cells.

And remember, David, also that home care is a category that is very sensitive to volume. And we see opportunities coming from the constraints in supply in the global market. You know, our supply chain is multipolar, is very resilient. We are seeing some shortage in some local players, particularly in India and Southeast Asia, that can support our volumes and it will make easier the passing of pricing in the future.

Thank you. Our next question comes from Jeremy at HSBC. Go ahead, Jeremy.

Hi, Morley. Thanks for taking the questions. A couple from me. First one is perhaps you could talk a little bit about what you're seeing from a consumer standpoint in some of the emerging markets, which on paper would be more affected by the higher oil price, particularly some of those around Southeast Asia, whether there's been anything you've noticed in terms of how consumers are behaving, their consumption patterns, or whether there isn't really a lot of evidence so far. And the second one is just on your margins. You talk about the margins being kind of like balanced in absolute terms between the first and second half, which on paper would mean that the margin expansion you deliver for 2026 would be coming basically all in the second half. So given that's when the commodity pressure would hit more, could you talk about what some of the other things you've got going in your favor in the second half to make sure that you land the margin numbers that you currently expect.

Thanks. Yeah, Jeremy, emerging markets, we have not seen any material changes in market volume growth at this stage. As I mentioned, we have been growing very nicely in places like Vietnam, Pakistan, Bangladesh, Arabia, India, Philippines. Probably the exception to that is Thailand, where, as I mentioned in David's questions, there has been a pricing issue that we have to sort out. But overall, you know, not material impact in consumption at this stage coming from the higher fuel prices that are starting to materialize in these countries. China, importantly for us, we have seen improvements in China since mid-2025. We are solidly now operating at around 5% growth. And as I mentioned before, particularly our food service business at China, is important in the context of China. We have seen some improvements in the out-of-home channel there that is supporting the growth of the food service business. Marcin?

So on the margins, I think there was a bit of a confusion in the marketplace in terms of whether you talk about the absolute margins on the BIPs. From a full year perspective, we had delivered margins of 20%. If you look at the prior two years, there was a bit of a lot more volatility and seasonality between half one and half two, with ice creams moving away. We were in the space of saying that, look, we're likely to have that steady margin profile from a first half and second half point of view. From a first half perspective, we are trending well, given all the actions that we have taken, given the volume-led growth and our gross margin progression. So we should see improvement at least of at least first half. Maintaining last year's margins or a slight improvement, that's what we're aiming for. Second half, we have discussed some of the cost challenges and some of the actions that we are taking. At this stage, we believe that we will have all the mitigants in place to cater to that, and therefore the overall approach. Best at this stage would be to really focus on how we want to navigate the environment, the situation, and deliver the model on a full year basis. And we could actually have a proper conversation at half one results with a better outlook on the full year.

Thank you. Our next question comes from Sarah at Morgan Stanley. Go ahead, Sarah.

Yes, good morning. Just following on from that sort of shape of the margin. Should we expect a significant skew in terms of marketing investment as a percentage of revenues between H1 and H2, given the FIFA stuff? Thanks.

No, we feel very comfortable with the investment that we are having in the market now. We believe that we can operate between 15% and 16% in terms of brand marketing investment. We have increased around 300 basis points, our investment behind the brands, in the last three years. So we feel comfortable with that kind of level. We measure that, of course, on a monthly basis. Our share of voice, both in the digital space and in the old media space, space is solid. And as I mentioned before, we will keep our competitiveness as a key metric of success for us, ensuring that the enablers of demand, both in terms of pricing and brand market investments, are solid. So don't expect significant changes in the level of investment that we should have in the two halves.

So just, again, a little more color, especially in the developing markets and what we have seen historically. I'm not saying that that plays out exactly. When these kind of levels of inflation do play out, people do, as an industry, as a category, people do make calibration between pricing and investments to ensure that they give the right value to the consumers. What effectively that means that the media hit could come off significantly. Our endeavor is to ensure that we invest adequately behind our brands. We do everything to support our innovations, but we will actually keep a lens if the media heat does come off, we will ensure that we are deploying our resources effectively and not really wasting some of the media money.

I feel it's important that history shows that when there is significant commodity inflation, there tends to be media deflation. So we will be looking at particular emerging markets, you know, so that's something that we are looking in detail and our procurement team is very active in that space.

Thank you. Our next question comes from Tom at Deutsche Bank. Go ahead, Tom.

Yeah, morning, everybody. Thank you. Just on the US, first of all, the share data in Nielsen suggests that you're losing share of the Amazon channel. And that channel seems to be growing rapidly. the fastest in HPC and personal care. You know, DAs and Bath and Shower are very strong on Amazon. From your perspective, do you think you're holding share on that channel, which seems to disproportionately be growing? And then on pricing on Amazon, it's not annual contracts, as I understand. And so in theory, you could put up pricing pretty quickly. Do you believe your pricing power or elasticity is the same on Amazon as it would be on other channels? And a final one, just in the follow up on the media, is there any element in your increase of use of influencers and KOLs etc that there is an inbuilt flexibility on what you pay them depending on volumes and so therefore that would naturally come down a bit if volumes in say EMs came down please yeah the the last question you know is influencer cost is a variable cost

You know, pricing, of course, it has a component of volume there. Regarding pricing in Amazon, you know, we don't see fundamental difference between our pricing ability in the Amazon channel and the offline channel. As you know, they are closely linked because you have to ensure that there are no pricing conflict across channels. So we don't see any fundamental issue there. You want to talk about shares?

So what we really follow, Tom, is Sarkana has been more representative of some of the shared trends, whether it is an Amazon or broader e-commerce, e-commerce. Therefore, progressively in the last 12, 18 months, we have validated the database, and that is what we actually look at. The reads that we see on that continue to show much better. So there is a divergence which is happening between the two data sources. But at an aggregate, we are not seeing some of the elements that you've spoken about, but happy to engage with you offline to go into further details.

Yeah, we are, you know, just, I don't have the latest number, but our growth in Amazon, it has been in the high teens for 2025. I need to check exactly what was in quarter one. I don't have that data here.

Thank you. Our next question comes from Guillaume at UBS. Go ahead, Guillaume.

Thank you very much. And good morning, Fernando, Srini and Gemma. Two questions for me, please. First one is on Europe. Kind of second consecutive quarter now that both USG and UVG are a bit soft. Wondering if it's mostly down to lower category growth or if you're also seeing some maybe challenges in terms of your market share development in an environment that seems to be highly promotional So maybe if you can unpack this performance for us, and I guess looking ahead, do you expect similar trends in Europe, or are you hopeful you can go back to positive USG and UVG in the next quarter? And then my second question is on foods. I appreciate it's really early days, but Fernando, I'm wondering how the business has been reacting following the announcement of the deal with McCormick. And between now and the completion of the deal, I mean, how to ensure that food doesn't get destructed too much by, you know, the carve-out, I'm sure for some employees, some job uncertainty. So I guess what will be the focus for food in the next four to five quarters? Thank you very much. Thank you, William.

Well, Europe, indeed, the market has been subdued. You know, we have had very good share progress in home care and personal care in the last, you know, nine to ten quarters. Foods has been a bit more difficult. It's 40% of our revenue there. And we have seen some increasing promotional pressure in foods. And that has put some negative impact on pricing that is affecting us, you know. But we expect our performance in Europe to improve along the year. We are really banking in a very strong quarter two in personal care with all the FIFA activation that in Europe will be very, very significant. We are starting to roll out some of our most successful video and web brands into Europe. So, you know, we don't expect Europe to become a key engine of growth in the future, but we expect a slight recovery, despite the fact that the impact of energy prices in Europe can be significant in terms of consumer purchasing power and confidence. So a slight improvement expected in Europe going forward. Regarding Foots, we have, of course, been very active communicating the transaction internally to our employees. I was recently in the Netherlands having a town hall with all our employees there in the central Foots team and talking to the whole Foots team across the globe. I believe there is some real excitement about the potential that the McCormick transaction offers for our people. It was very clear that Foots was not a key priority in terms of portfolio development within Unilever. But Knorr will be the number one brand in the enlarged McCormick, and Hellmann's will be the number two brand in the enlarged McCormick. So the concept of building a real global flavor powerhouse with significant revenue synergies in what I call a growth separation of foods, I believe it's resonating with our people. Of course, there is some anxiety, and we are working very aligned with McCormick to ensure that we shorten timeframes in every single world stream. We are working very collaboratively with the McCormick leadership team. Separation work streams are all in motion. And the integration plan with McCormick is being managed in conjunction between the two companies. This week, the McCormick leadership team is here in Europe. We have been talking to them. They have been presented to some of you, I believe, also. And, you know, we are very, very happy with the progress that we are doing. And the intention is to shorten timings as much as we can.

Thank you. Our final question comes from Ed at Rothschild. Go ahead, Ed.

Yes, thanks very much. A couple of ones. Just looking at the Asia-Pac and LATAM, you referenced beauty and well-being, strong performance in LATAM, also beauty and well-being driving growth in China. Just trying to understand what parts of the VC and well-being are growing there. Is it the more premium side of the business? Is it largely online-led? Just to sort of understand how you're positioned there. And then as we think about a period of more macro uncertainty, how should we think about the one Unilever market in that context? Do you feel more confident about being able to navigate potential uncertainty or macro uncertainty given the you know, the way you now run those one-year lever markets.

Yeah. Thank you, Ed. Yeah, performance in beauty and well-being in emerging markets has been strong. As I mentioned before, our hair business grew high single digits at total level, and that was driven by strong performance in emerging markets. India grew 8%. You know, I feel in Latin America, beauty and well-being was, I believe, in double-digit growth. We are seeing strong growth also in the Middle East and in some other Southeast Asia. So I feel the performance has been strong. We have an excellent performance of Abgea. Abgea is growing 15%. It initiated with a relaunch in the U.S. that is performing extremely well, but now this relaunch is rolled out across all our geographies. Vaseline is growing very, very strongly, close to 10%, and Sunseal is growing 8% in butane well-being. So if you look at the top three brands of our beauty and well-being business. You know, Dabhair, 15%, Vaseline, 9%, if I'm not wrong, and Sunseal, 8%. So performance is strong. It's strong in different price points, particularly in the upper-mass to premium segment. But also, as I mentioned before, our prestige business in the U.S. is also doing very, very well. So overall, good performance in beauty and well-being, particularly in emerging markets. Regarding one-year lever markets, we are very happy with the performance there. It has been one of our fastest-growing clusters last year. Performance in quarter one continues being strong. We are running in one-year lever markets a much more tighter portfolio. Usually in every market in what we call one-year lever, that are markets 25 onwards, we run a portfolio between six and eight brands. And in the quarter one, we deliver about 2% volume once again. So we believe that it could be, as I mentioned before, opportunities for us in these markets to When there are supply constraints in the market, there are two things that happen. A resilient supply chain like the one of Unilever can build some competitive advantage to drive more volume. And second, the ability to pass pricing is higher.

Thank you very much.

Good. I would like to close with a couple of messages. The first one is that we started the year, as I mentioned, with a strong volume growth and our confidence in delivering about 2% volume growth for the year is reinforced by the fact that we are having a strong start to quarter two with practically April finish now. Pricing will definitely accelerate along the year. The majority of our cost inflation is in home care and is in emerging markets and the frequency of pricing and the ability to pass pricing in these regions is higher. The cost environment is volatile, but we will manage the business with clear focus on volume and ensuring competitiveness in both price and BMI. And as I mentioned before, we will emphasize the driver of demand with the highest return, depending on the environment. We are really making good progress regarding the food separation. Of course, there are elements that are not completely in our control, like the timing of the antitrust clearance. and the timing of the SEC approval but all the work streams are in motion we are working as one team with the McCormick leadership team and we expect to really accelerate the timing of separation and integration and we are reaffirming our guidance we continue expecting our top line to grow within the range of four to six percent most probably at the bottom end of the of that range, and we expect, despite the increasing commodity inflation that we expect hitting our P&L in the second half of the year, to deliver modest operating margin. We will use every single level of the P&L, from formulation, flexibility, to productivity, to hiring threes, to tighter overhead management, to ensure that we are able to deliver the modest operating margin expansion that is in our guidance. With that, thank you very much.